Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity
Prostate apoptosis response-4 (Par-4) is a tumor suppressor that induces apoptosis in cancer cells. However, the physiological function of Par-4 remains unknown. Here we show that conventional Par-4 knockout (Par-4 ) mice and adipocyte-specific Par-4 knockout (AKO) mice, but not hepatocyte-specific...
Saved in:
Published in: | Frontiers in oncology Vol. 12; p. 860446 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Media S.A
29-03-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Prostate apoptosis response-4 (Par-4) is a tumor suppressor that induces apoptosis in cancer cells. However, the physiological function of Par-4 remains unknown. Here we show that conventional Par-4 knockout (Par-4
) mice and adipocyte-specific Par-4 knockout (AKO) mice, but not hepatocyte-specific Par-4 knockout mice, are obese with standard chow diet. Par-4
and AKO mice exhibit increased absorption and storage of fat in adipocytes. Mechanistically, Par-4 loss is associated with
downregulation and activation of p53. We identified complement factor
as a p53-regulated gene linked to fat storage in adipocytes.
re-expression in adipocytes or
deletion reversed the obese mouse phenotype. Moreover, obese human subjects showed lower expression of Par-4 relative to lean subjects, and in longitudinal studies, low baseline Par-4 levels denoted an increased risk of developing obesity later in life. These findings indicate that Par-4 suppresses p53 and its target
to regulate obesity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Philipp E. Scherer, University of Texas Southwestern Medical Center, United States; Andreas Prokesch, Medical University of Graz, Austria; Isabel Reinisch, Medical University of Graz, in collaboration with reviewer AP This article was submitted to Cancer Metabolism, a section of the journal Frontiers in Oncology These authors have contributed equally to this work and share first authorship Edited by: Che-Pei Kung, Washington University in St. Louis, United States |
ISSN: | 2234-943X 2234-943X |
DOI: | 10.3389/fonc.2022.860446 |